ID

38050

Description

Ruxolitinib in Patients With Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01562873

Link

https://clinicaltrials.gov/show/NCT01562873

Keywords

Versions (1)
  1. 9/12/19 9/12/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

September 12, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Breast Cancer NCT01562873

English

Eligibility Breast Cancer NCT01562873

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically or cytologically confirmed invasive breast cancer
Description

Invasive carcinoma of breast

Data type

boolean

Alias
UMLS CUI [1]
C0853879
must have known er, pr and her2 status
Description

Estrogen Receptor Status Known | Progesterone Receptor Status Known | HER2 Status Known

Data type

boolean

Alias
UMLS CUI [1,1]
C1516974
UMLS CUI [1,2]
C0205309
UMLS CUI [2,1]
C1514471
UMLS CUI [2,2]
C0205309
UMLS CUI [3,1]
C1512413
UMLS CUI [3,2]
C0205309
either, triple negative metastatic breast cancer or
Description

Triple Negative Breast Neoplasm metastatic

Data type

boolean

Alias
UMLS CUI [1,1]
C3539878
UMLS CUI [1,2]
C1522484
inflammatory breast cancer with any er, pr her2 status
Description

Inflammatory Breast Carcinoma | Estrogen Receptor Status Any | Progesterone Receptor Status Any | HER2 Status Any

Data type

boolean

Alias
UMLS CUI [1]
C0278601
UMLS CUI [2,1]
C1516974
UMLS CUI [2,2]
C1552551
UMLS CUI [3,1]
C1514471
UMLS CUI [3,2]
C1552551
UMLS CUI [4,1]
C1512413
UMLS CUI [4,2]
C1552551
availability of archival tissue specimen suitable for pstat3 testing
Description

Availability of Tissue specimen | Other Coding | STAT3 Testing

Data type

boolean

Alias
UMLS CUI [1,1]
C0470187
UMLS CUI [1,2]
C1292533
UMLS CUI [2]
C3846158
UMLS CUI [3,1]
C1367307
UMLS CUI [3,2]
C0039593
life expectancy of greater than 3 months
Description

Life Expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0023671
measurable disease by recist
Description

Measurable Disease

Data type

boolean

Alias
UMLS CUI [1]
C1513041
at least one prior chemotherapy regimen for treatment of metastatic breast cancer and/or recurrence within 12 months of completion of neoadjuvant/adjuvant chemotherapy or
Description

Prior Chemotherapy Quantity Secondary malignant neoplasm of female breast | Recurrence | Neoadjuvant Chemotherapy Completion | Adjuvant Chemotherapy Completion

Data type

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0346993
UMLS CUI [2]
C0034897
UMLS CUI [3,1]
C0600558
UMLS CUI [3,2]
C3665472
UMLS CUI [3,3]
C0205197
UMLS CUI [4,1]
C0085533
UMLS CUI [4,2]
C0205197
for patients with inflammatory breast cancer but no distant metastases, progression through standard neoadjuvant chemotherapy is required
Description

Inflammatory Breast Carcinoma | Distant metastasis Absent | Progression | Etiology Neoadjuvant Chemotherapy

Data type

boolean

Alias
UMLS CUI [1]
C0278601
UMLS CUI [2,1]
C1269798
UMLS CUI [2,2]
C0332197
UMLS CUI [3]
C0449258
UMLS CUI [4,1]
C0015127
UMLS CUI [4,2]
C0600558
UMLS CUI [4,3]
C3665472
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant or breastfeeding
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
active brain metastases
Description

Metastatic malignant neoplasm to brain

Data type

boolean

Alias
UMLS CUI [1]
C0220650
history of allergic reactions attributed to compounds of similar chemical or biologic composition to ruxolitinib
Description

Allergic Reaction Ruxolitinib Compound Similar

Data type

boolean

Alias
UMLS CUI [1,1]
C1527304
UMLS CUI [1,2]
C2931926
UMLS CUI [1,3]
C1706082
UMLS CUI [1,4]
C2348205
clinically significant malabsorption syndrome
Description

Malabsorption Syndrome

Data type

boolean

Alias
UMLS CUI [1]
C0024523
concurrent use of medications/substances that are strong inhibitors of cy3a4
Description

CYP3A4 Inhibitors Strong

Data type

boolean

Alias
UMLS CUI [1,1]
C3850053
UMLS CUI [1,2]
C0442821
no uncontrolled intercurrent illness
Description

Comorbidity Uncontrolled

Data type

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205318
Back to the top of the page

Similar models

Eligibility Breast Cancer NCT01562873

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Invasive carcinoma of breast
Item
histologically or cytologically confirmed invasive breast cancer
boolean
C0853879 (UMLS CUI [1])
Estrogen Receptor Status Known | Progesterone Receptor Status Known | HER2 Status Known
Item
must have known er, pr and her2 status
boolean
C1516974 (UMLS CUI [1,1])
C0205309 (UMLS CUI [1,2])
C1514471 (UMLS CUI [2,1])
C0205309 (UMLS CUI [2,2])
C1512413 (UMLS CUI [3,1])
C0205309 (UMLS CUI [3,2])
Triple Negative Breast Neoplasm metastatic
Item
either, triple negative metastatic breast cancer or
boolean
C3539878 (UMLS CUI [1,1])
C1522484 (UMLS CUI [1,2])
Inflammatory Breast Carcinoma | Estrogen Receptor Status Any | Progesterone Receptor Status Any | HER2 Status Any
Item
inflammatory breast cancer with any er, pr her2 status
boolean
C0278601 (UMLS CUI [1])
C1516974 (UMLS CUI [2,1])
C1552551 (UMLS CUI [2,2])
C1514471 (UMLS CUI [3,1])
C1552551 (UMLS CUI [3,2])
C1512413 (UMLS CUI [4,1])
C1552551 (UMLS CUI [4,2])
Availability of Tissue specimen | Other Coding | STAT3 Testing
Item
availability of archival tissue specimen suitable for pstat3 testing
boolean
C0470187 (UMLS CUI [1,1])
C1292533 (UMLS CUI [1,2])
C3846158 (UMLS CUI [2])
C1367307 (UMLS CUI [3,1])
C0039593 (UMLS CUI [3,2])
Life Expectancy
Item
life expectancy of greater than 3 months
boolean
C0023671 (UMLS CUI [1])
Measurable Disease
Item
measurable disease by recist
boolean
C1513041 (UMLS CUI [1])
Prior Chemotherapy Quantity Secondary malignant neoplasm of female breast | Recurrence | Neoadjuvant Chemotherapy Completion | Adjuvant Chemotherapy Completion
Item
at least one prior chemotherapy regimen for treatment of metastatic breast cancer and/or recurrence within 12 months of completion of neoadjuvant/adjuvant chemotherapy or
boolean
C1514457 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0346993 (UMLS CUI [1,3])
C0034897 (UMLS CUI [2])
C0600558 (UMLS CUI [3,1])
C3665472 (UMLS CUI [3,2])
C0205197 (UMLS CUI [3,3])
C0085533 (UMLS CUI [4,1])
C0205197 (UMLS CUI [4,2])
Inflammatory Breast Carcinoma | Distant metastasis Absent | Progression | Etiology Neoadjuvant Chemotherapy
Item
for patients with inflammatory breast cancer but no distant metastases, progression through standard neoadjuvant chemotherapy is required
boolean
C0278601 (UMLS CUI [1])
C1269798 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0449258 (UMLS CUI [3])
C0015127 (UMLS CUI [4,1])
C0600558 (UMLS CUI [4,2])
C3665472 (UMLS CUI [4,3])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding
Item
pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Metastatic malignant neoplasm to brain
Item
active brain metastases
boolean
C0220650 (UMLS CUI [1])
Allergic Reaction Ruxolitinib Compound Similar
Item
history of allergic reactions attributed to compounds of similar chemical or biologic composition to ruxolitinib
boolean
C1527304 (UMLS CUI [1,1])
C2931926 (UMLS CUI [1,2])
C1706082 (UMLS CUI [1,3])
C2348205 (UMLS CUI [1,4])
Malabsorption Syndrome
Item
clinically significant malabsorption syndrome
boolean
C0024523 (UMLS CUI [1])
CYP3A4 Inhibitors Strong
Item
concurrent use of medications/substances that are strong inhibitors of cy3a4
boolean
C3850053 (UMLS CUI [1,1])
C0442821 (UMLS CUI [1,2])
Comorbidity Uncontrolled
Item
no uncontrolled intercurrent illness
boolean
C0009488 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial